Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BIOLASE Inc

BIOL
Current price
1.51 USD +0.32 USD (+26.89%)
Last closed 1.15 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 2 641 297 USD
Yield for 12 month +83.79 %
Week
Month
Year
BIOL
21.11.2021 - 28.11.2021

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. Address: 27042 Towne Centre Drive, Foothill Ranch, CA, United States, 92610-2811

Analytics

WallStreet Target Price

21.38 USD

P/E ratio

Dividend Yield

Current Year

+48 462 000 USD

Last Year

+39 188 000 USD

Current Quarter

+10 921 000 USD

Last Quarter

+14 286 000 USD

Current Year

+15 911 000 USD

Last Year

+16 529 000 USD

Current Quarter

+3 746 000 USD

Last Quarter

+6 118 000 USD

Key Figures BIOL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -18 227 000 USD
Operating Margin TTM -33.85 %
PE Ratio
Return On Assets TTM -31.38 %
PEG Ratio -0.22
Return On Equity TTM -254.96 %
Wall Street Target Price 21.38 USD
Revenue TTM 49 725 000 USD
Book Value 0.15 USD
Revenue Per Share TTM 92.94 USD
Dividend Share
Quarterly Revenue Growth YOY -9.1 %
Dividend Yield
Gross Profit TTM 16 529 000 USD
Earnings Share -150.55 USD
Diluted Eps TTM -150.55 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -50.61 %

Dividend Analytics BIOL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BIOL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 24.06.2005
Forward Annual Dividend Yield
Last Split Factor 1:100
Payout Ratio
Last Split Date 28.07.2023
Dividend Date 11.05.2018

Stock Valuation BIOL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.3001
Price Sales TTM 0.0531
Enterprise Value EBITDA -0.7631
Price Book MRQ 3.6154

Financials BIOL

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BIOL

For 52 weeks

1.07 USD 88.66 USD
50 Day MA 1.55 USD
Shares Short Prior Month 8 569
200 Day MA 13.61 USD
Short Ratio 0.25
Shares Short 100 472
Short Percent 9.64 %